Research Focus
Dr. Guerrero-Arguero is a virologist and immunologist originally from Guadalajara, Mexico. He completed a PhD at Brigham Young University, focusing on the role of macrophages in Chikungunya virus pathogenesis. He subsequently underwent postdoctoral training at Texas Biomedical Research Institute, where he gained experience working with respiratory pathogens such as SARS-CoV-2, influenza virus, and Mycobacterium tuberculosis.
Presently, Dr. Guerrero-Arguero serves as a virologist in the Applied Science and Innovation (ASI) department at Texas Biomedical Research Institute. In this role, he participates in contract research studies supporting the development and evaluation of medical countermeasures against high-consequence pathogens. His work includes the design and execution of virology assays conducted in Biosafety Level 3 (BSL-3) and Biosafety Level 4 (BSL-4) containment laboratories, supporting vaccine, antiviral, and therapeutic efficacy studies. He has hands-on experience working with a broad range of high-consequence viruses, including arenaviruses, filoviruses, henipaviruses, and alphaviruses.
In addition to his ASI responsibilities, his research interests center on understanding host–pathogen interactions between human immune cells and alphaviruses. He is particularly interested in establishing and applying humanized mouse models to investigate viral pathogenesis and to support the development of vaccines and therapeutic interventions.
Beyond his research endeavors, Dr. Guerrero-Arguero is deeply committed to education and science communication. He actively collaborates with the Texas Biomed Education Outreach team, participating in educational outreach programs that engage community youth and diverse audiences, reflecting his dedication to fostering scientific literacy and public understanding of biomedical research.